Log in to save to my catalogue

Low expression of Aldo–keto reductase 1B10 is a novel independent prognostic indicator for nasophary...

Low expression of Aldo–keto reductase 1B10 is a novel independent prognostic indicator for nasophary...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4779195

Low expression of Aldo–keto reductase 1B10 is a novel independent prognostic indicator for nasopharyngeal carcinoma

About this item

Full title

Low expression of Aldo–keto reductase 1B10 is a novel independent prognostic indicator for nasopharyngeal carcinoma

Publisher

England: BioMed Central Ltd

Journal title

Cell & bioscience, 2016-03, Vol.6 (1), p.18-18, Article 18

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Nasopharyngeal carcinoma (NPC) is one of the most common human head and neck cancers with high incidence in Southern China, Southeast Asia and North Africa. Because of its nonspecific symptoms, the early diagnosis of NPC is very difficult. The 5-year survival rate is not ideal in spite of great innovations in radiation and chemotherapy treatments....

Alternative Titles

Full title

Low expression of Aldo–keto reductase 1B10 is a novel independent prognostic indicator for nasopharyngeal carcinoma

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4779195

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4779195

Other Identifiers

ISSN

2045-3701

E-ISSN

2045-3701

DOI

10.1186/s13578-016-0082-x

How to access this item